Literature DB >> 31787858

Novel Therapies for Cholestatic Liver Disease.

Cynthia Levy1.   

Abstract

Entities:  

Year:  2019        PMID： 31787858      PMCID： PMC6875878     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  9 in total

1.  Use of Fenofibrate for patients with primary Sclerosing Cholangitis.

Authors:  Sherine M Abdalla; Adriana Dejman; Virginia Clark; Cynthia Levy
Journal:  Clin Res Hepatol Gastroenterol       Date:  2019-03-14       Impact factor: 2.947

2.  Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.

Authors:  Jessica R Allegretti; Zain Kassam; Madeline Carrellas; Benjamin H Mullish; Julian R Marchesi; Alexandros Pechlivanis; Mark Smith; Ylaine Gerardin; Sonia Timberlake; Daniel S Pratt; Joshua R Korzenik
Journal:  Am J Gastroenterol       Date:  2019-07       Impact factor: 10.864

3.  A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.

Authors:  Christophe Corpechot; Olivier Chazouillères; Alexandra Rousseau; Antonia Le Gruyer; François Habersetzer; Philippe Mathurin; Odile Goria; Pascal Potier; Anne Minello; Christine Silvain; Armand Abergel; Maryline Debette-Gratien; Dominique Larrey; Olivier Roux; Jean-Pierre Bronowicki; Jérôme Boursier; Victor de Ledinghen; Alexandra Heurgue-Berlot; Eric Nguyen-Khac; Fabien Zoulim; Isabelle Ollivier-Hourmand; Jean-Pierre Zarski; Gisèle Nkontchou; Sara Lemoinne; Lydie Humbert; Dominique Rainteau; Guillaume Lefèvre; Luc de Chaisemartin; Sylvie Chollet-Martin; Farid Gaouar; Farid-Hakeem Admane; Tabassome Simon; Raoul Poupon
Journal:  N Engl J Med       Date:  2018-06-07       Impact factor: 91.245

Review 4.  Novel and emerging therapies for cholestatic liver diseases.

Authors:  Jordan Goldstein; Cynthia Levy
Journal:  Liver Int       Date:  2018-06-14       Impact factor: 5.828

Review 5.  Understanding and Treating Pruritus in Primary Biliary Cholangitis.

Authors:  Andres F Carrion; Jordan D Rosen; Cynthia Levy
Journal:  Clin Liver Dis       Date:  2018-05-17       Impact factor: 6.126

6.  Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study.

Authors:  David Jones; Pol F Boudes; Mark G Swain; Christopher L Bowlus; Michael R Galambos; Bruce R Bacon; Yvonne Doerffel; Norman Gitlin; Stuart C Gordon; Joseph A Odin; David Sheridan; Markus-Alexander Wörns; Virginia Clark; Linsey Corless; Heinz Hartmann; Mark E Jonas; Andreas E Kremer; George F Mells; Peter Buggisch; Bradley L Freilich; Cynthia Levy; John M Vierling; David E Bernstein; Marek Hartleb; Ewa Janczewska; Fedja Rochling; Hemant Shah; Mitchell L Shiffman; John H Smith; Yun-Jung Choi; Alexandra Steinberg; Monika Varga; Harinder Chera; Robert Martin; Charles A McWherter; Gideon M Hirschfield
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-08-14

7.  A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.

Authors:  Frederik Nevens; Pietro Andreone; Giuseppe Mazzella; Simone I Strasser; Christopher Bowlus; Pietro Invernizzi; Joost P H Drenth; Paul J Pockros; Jaroslaw Regula; Ulrich Beuers; Michael Trauner; David E Jones; Annarosa Floreani; Simon Hohenester; Velimir Luketic; Mitchell Shiffman; Karel J van Erpecum; Victor Vargas; Catherine Vincent; Gideon M Hirschfield; Hemant Shah; Bettina Hansen; Keith D Lindor; Hanns-Ulrich Marschall; Kris V Kowdley; Roya Hooshmand-Rad; Tonya Marmon; Shawn Sheeron; Richard Pencek; Leigh MacConell; Mark Pruzanski; David Shapiro
Journal:  N Engl J Med       Date:  2016-08-18       Impact factor: 91.245

8.  A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis.

Authors:  Marlyn J Mayo; Paul J Pockros; David Jones; Christopher L Bowlus; Cynthia Levy; Imran Patanwala; Bruce Bacon; Velimir Luketic; Raj Vuppalanchi; Sharon Medendorp; Alejandro Dorenbaum; Ciara Kennedy; Patricia Novak; Joan Gu; George Apostol; Gideon M Hirschfield
Journal:  Hepatol Commun       Date:  2019-02-01

9.  NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Marlyn J Mayo; Alan J Wigg; Barbara A Leggett; Hays Arnold; Alexander J Thompson; Martin Weltman; Elizabeth J Carey; Andrew J Muir; Lei Ling; Stephen J Rossi; Alex M DePaoli
Journal:  Hepatol Commun       Date:  2018-08-30
  9 in total
  1 in total

Review 1.  NADPH oxidase family proteins: signaling dynamics to disease management.

Authors:  Rizwana Begum; Shilpa Thota; Abubakar Abdulkadir; Gagandeep Kaur; Prathyusha Bagam; Sanjay Batra
Journal:  Cell Mol Immunol       Date:  2022-05-18       Impact factor: 22.096
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.